Nature communications
Intermittent fasting inhibits Tp53-driven glioma through gut microbiota-mediated methionine-m6A regulation.
Yao Lin, ShihJung Li, Xinyue Xu, Xiaopeng Hu, Yueqi Li, Shuaiyi Liang, Jun Meng, Honglei Li, Zheng Li, Dandan Xiong, Hubin Chen, Jingzhen Lai, Yi Bao, Ziyi Liu, Jiemei Chu
Published: 202610.1038/s41467-026-68512-2
Abstract
Intermittent fasting (IF) has emerged as a potential cancer treatment modality, although its tumor-suppressive effects are limited. Glioblastoma (GBM) can be classified into CDKN2A subtype and TP53 subtype. Here, we discover that the efficacy of IF i…
Preview only. Read the full abstract at the source